Original Research
Accepted on 19 Feb 2025
Therapeutic Potential of Isochlorogenic Acid A from Taraxacum officinale in Improving Immune Response and Enhancing the Efficacy of PD-1/PD-L1 blockade in Triple-Negative Breast Cancer
in Cancer Immunity and Immunotherapy